In the published article, there was an error in the author contributions, and author Yinfeng Lyu should be added a token indicating equal contribution Yinfeng Lyu†. The corrected author list appears below.
Kunping Li 1†, Yuqing Li 1†, Yinfeng Lyu 1†, Linyi Tan 1, Xinyi Zheng 2, Haowen Jiang 1*, Hui Wen 1* and Chenchen Feng 1,2,3,*
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Statements
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
clear-cell renal cell carcinoma, antibody-dependent cellular phagocytosis, immune checkpoint inhibition, biomarker, bioinformatics
Citation
Li K, Li Y, Lyu Y, Tan L, Zheng X, Jiang H, Wen H and Feng C (2023) Corrigendum: Development of a phagocytosis- dependent gene signature to predict prognosis and response to checkpoint inhibition in clear-cell renal cell carcinoma. Front. Immunol. 14:1140764. doi: 10.3389/fimmu.2023.1140764
Received
09 January 2023
Accepted
10 January 2023
Published
19 January 2023
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
14 - 2023
Updates
Copyright
© 2023 Li, Li, Lyu, Tan, Zheng, Jiang, Wen and Feng.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Hui Wen, drwenhui@163.com; Haowen Jiang, drjianghaowen@163.com; Chenchen Feng, drfengchenchen@163.com
†These authors have contributed equally to this work
This article was submitted to Cancer Immunity and Immunotherapy, a section of the journal Frontiers in Immunology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.